Repligen Reaches Analyst Target Price - Nasdaq

Dec 15, 2023 · In recent trading, shares of Repligen Corp. (Symbol: RGEN) have crossed above the average analyst 12-month target price of $176.50, changing hands for $180.41/share. When a stock reaches the ...

$176.50
OFF

Repligen Reaches Analyst Target Price - Nasdaq

2 weeks from now

nasdaq.com

$185.20
OFF

Repligen (RGEN) Stock Forecast And Price Target 2025 - MarketBeat

2 weeks from now

6 days ago · According to the 13 analysts' twelve-month price targets for Repligen, the average price target is $185.20. The highest price target for RGEN is $220.00, while the lowest price …

marketbeat.com

10%
OFF

Repligen Corporation (RGEN) Stock Forecast & Price Targets

2 weeks from now

5 days ago · NASDAQ: RGEN · Real-Time Price · USD. Watchlist Compare. 154.86 +0.16 (0.10%) At close: Jan 10, 2025, 4:00 PM. ... Analyst Ratings; Repligen Stock Forecast. All …

stockanalysis.com

$165.00
OFF

Repligen (NASDAQ:RGEN) Stock, Analyst Ratings, Price Targets

2 weeks from now

Dec 31, 2018 · The latest price target for Repligen (NASDAQ:RGEN) was reported by Canaccord Genuity on December 17, 2024. The analyst firm set a price target for $165.00 expecting …

benzinga.com

$189.17
OFF

Analyst Ratings For Repligen - Markets Insider

2 weeks from now

Dec 20, 2023 · Insights from analysts' 12-month price targets are revealed, presenting an average target of $189.17, a high estimate of $210.00, and a low estimate of $165.00.

businessinsider.com

$185.20
OFF

RGEN Stock Price Target | Repligen Analyst Ratings

2 weeks from now

74 rows · This price target is based on 13 analysts offering 12 month price targets for Repligen in the last 3 months. The average price target is $185.20, with a high forecast of $220.00 and a …

pricetargets.com

$211
OFF

Repligen Corporation: Target Price Consensus And Analysts ...

2 weeks from now

1 day ago · UBS Adjusts Repligen Price Target to $211 From $170, Maintains Buy Rating 23-12-15: MT Benchmark Downgrades Repligen to Hold From Buy 23-12-04: MT Deutsche Bank …

marketscreener.com

$180.00
OFF

Repligen: A Strong Buy On Strategic M&A And Promising Growth …

2 weeks from now

Sep 9, 2024 · Analyst Brandon Couillard from Wells Fargo maintained a Buy rating on Repligen (RGEN – Research Report) and keeping the price target at $180.00.. Brandon Couillard has …

businessinsider.com

$207
OFF

RBC Lifts Price Target On Repligen To $207 From $205, Keeps …

2 weeks from now

Dec 9, 2024 · -- Repligen has an average rating of overweight and mean price target of $193.25, according to analysts polled by FactSet. ...

marketscreener.com

$211.86
OFF

RGEN Crosses Above Average Analyst Target - Nasdaq

2 weeks from now

Feb 25, 2021 · In recent trading, shares of Repligen Corp. (Symbol: RGEN) have crossed above the average analyst 12-month target price of $211.86, changing hands for $215.58/share. …

nasdaq.com

05%
OFF

Repligen Corp Stock Forecast, Predictions & Price Target

2 weeks from now

On average, Wall Street analysts predict. that Repligen's share price could reach $184.17 by Dec 17, 2025. The average Repligen stock price prediction forecasts a potential upside of 19.05% …

wallstreetzen.com

$183.58
OFF

Repligen Reaches Analyst Target Price - Nasdaq

2 weeks from now

In recent trading, shares of Repligen Corp. (Symbol: RGEN) have crossed above the average analyst 12-month target price of $183.58, changing hands for $184.22/share. When a stock …

nasdaq.com

$165
OFF

Repligen Initiated With A Hold At Canaccord - Nasdaq

2 weeks from now

Dec 16, 2024 · Canaccord initiated coverage of Repligen (RGEN) with a Hold rating and $165 price target The company delivers configurable bioprocessing products and systems that are …

nasdaq.com

$1038.68
OFF

Forecasting The Future: 22 Analyst Projections For Regeneron

2 weeks from now

4 days ago · Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $1038.68, with a high estimate of $1260.00 and a low estimate of $165.00.

nasdaq.com

FAQs about Repligen Reaches Analyst Target Price - Nasdaq Coupon?

Where can I buy Repligen stock?

You can buy shares of Repligen (RGEN) stock through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. To check the current stock price, see What is Repligen's stock price today? ...

What are Repligen's 1-year price targets?

The 1-year price target range for Repligen's stock is from $165.00 to $240.00. Nine brokers have issued these forecasts, with an average expectation of the company's share price reaching $199.44 in the next twelve months, suggesting a possible upside of 21.8% from the current price. ...

How do analysts evaluate Repligen (Repligen) stock?

This information offers a snapshot of how analysts perceive the current state of the company. Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Repligen compared to the broader market. ...

How much profit does Repligen make a year?

Repligen (NASDAQ:RGEN) generates $185.96 million in net income (profit) each year. The biotechnology company has a market capitalization of $9.13 billion and 2,025 employees. ...

What are analysts' 12-month price targets?

Insights from analysts' 12-month price targets are revealed, presenting an average target of $189.17, a high estimate of $210.00, and a low estimate of $165.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 7.5%. ...

What is Repligen Corporation?

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. ...